---
title: "GenSci128 Receives Orphan Drug Designation for Pancreatic Cancer Treatment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278534545.md"
description: "Changchun High-Tech's subsidiary, Changchun GeneScience Pharmaceuticals, has received orphan drug designation from the U.S. FDA for GenSci128, aimed at treating pancreatic cancer. This designation is a crucial advancement for the company, offering benefits like market exclusivity and potential tax credits to support the drug's development and commercialization."
datetime: "2026-03-10T10:12:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278534545.md)
  - [en](https://longbridge.com/en/news/278534545.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278534545.md)
---

# GenSci128 Receives Orphan Drug Designation for Pancreatic Cancer Treatment

Changchun High-Tech announced that its subsidiary, Changchun GeneScience Pharmaceuticals Co., Ltd., has received notification from the U.S. Food and Drug Administration granting orphan drug designation to GenSci128 for the treatment of pancreatic cancer. According to Jin10, this designation is a significant step for the company in advancing its efforts to address this challenging disease. The orphan drug status is expected to provide certain benefits, including market exclusivity and potential tax credits, which could aid in the development and commercialization of GenSci128.

### Related Stocks

- [000661.CN](https://longbridge.com/en/quote/000661.CN.md)

## Related News & Research

- [Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer | SLXN Stock News](https://longbridge.com/en/news/286425411.md)
- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)
- [Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News](https://longbridge.com/en/news/286772951.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)